Moderna’s Personalized Cancer Vaccine Scores Late-Stage Win
Moderna and Merck say their personalized mRNA cancer vaccine significantly reduced the risk of melanoma returning or spreading.
Moderna and Merck say their personalized mRNA cancer vaccine significantly reduced the risk of melanoma returning or spreading.
Get up-to-the-minute news sent straight to your device.